Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Stroke

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 147 articles:
HTML format
Text format



Single Articles


    November 2019
  1. SCHNABEL RB, Haeusler KG, Healey JS, Freedman B, et al
    Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
    Circulation. 2019;140:1834-1850.
    PubMed     Text format     Abstract available


    July 2019
  2. HOPEWELL JC, Ibrahim M, Hill M, Shaw PM, et al
    Impact of ADCY9 Genotype on Response to Anacetrapib.
    Circulation. 2019 Jul 23. doi: 10.1161/CIRCULATIONAHA.119.041546.
    PubMed     Text format     Abstract available


    June 2019
  3. JOHNSTON SC, Elm JJ, Easton JD, Farrant M, et al
    Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial.
    Circulation. 2019 Jun 26. doi: 10.1161/CIRCULATIONAHA.119.040713.
    PubMed     Text format     Abstract available


    March 2019
  4. GROTTA JC
    Interhospital Transfer of Stroke Patients for Endovascular Treatment.
    Circulation. 2019;139:1578-1580.
    PubMed     Text format    


    February 2019
  5. HYLEK EM
    Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation.
    Circulation. 2019;139:772-774.
    PubMed     Text format    


    January 2019
  6. OKAZAKI S, Morimoto T, Kamatani Y, Kamimura T, et al
    Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.
    Circulation. 2019;139:295-298.
    PubMed     Text format    


  7. SCHWAMM LH
    Digital Health Strategies to Improve Care and Continuity Within Stroke Systems of Care in the United States.
    Circulation. 2019;139:149-151.
    PubMed     Text format    


  8. VANHAVERBEKE M, Bogaerts K, Sinnaeve PR, Janssens L, et al
    Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:137-139.
    PubMed     Text format    


    December 2018
  9. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Circulation. 2018;138:2908-2918.
    PubMed     Text format     Abstract available


  10. VERMA S, Poulter NR, Bhatt DL, Bain SC, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
    Circulation. 2018;138:2884-2894.
    PubMed     Text format     Abstract available


  11. DIDIER R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, et al
    Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
    Circulation. 2018;138:2597-2607.
    PubMed     Text format     Abstract available


  12. KIM MK, Han K, Park YM, Kwon HS, et al
    Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Circulation. 2018;138:2627-2637.
    PubMed     Text format     Abstract available


    November 2018
  13. SAVITZ SI, Yavagal D, Rappard G, Likosky W, et al
    A Phase 2 Randomized, Sham Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow Derived ALD-401 Cells in Patients with Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.117.030659.
    PubMed     Text format     Abstract available


  14. ROCHA RV, Tam DY, Karkhanis R, Nedadur R, et al
    Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.
    Circulation. 2018;138:2081-2090.
    PubMed     Text format     Abstract available


    October 2018
  15. DI BIASE L, Natale A, Romero J
    Thrombogenic and Arrhythmogenic Roles of the Left Atrial Appendage in Atrial Fibrillation.
    Circulation. 2018;138:2036-2050.
    PubMed     Text format     Abstract available


  16. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    PubMed     Text format     Abstract available


  17. CHAO TF, Chiang CE, Lin YJ, Chang SL, et al
    Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.
    Circulation. 2018;138:1485-1487.
    PubMed     Text format    


  18. MAHESHWARI A, Norby FL, Roetker NS, Soliman EZ, et al
    Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score: The Atherosclerosis Risk in Communities (ARIC) Study and Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2018 Oct 2. doi: 10.1161/CIRCULATIONAHA.118.035411.
    PubMed     Text format     Abstract available


    September 2018
  19. GEORGAKIS MK, Gill D, Rannikmae K, Traylor M, et al
    Genetically Determined Levels of Circulating Cytokines and Risk of Stroke: Role of Monocyte Chemoattractant Protein-1.
    Circulation. 2018 Sep 26. doi: 10.1161/CIRCULATIONAHA.118.035905.
    PubMed     Text format     Abstract available


  20. MENON BK, Xu H, Cox M, Saver JL, et al
    Components and Trends in Door to Treatment Times for Endovascular Therapy in GWTG-Stroke Hospitals.
    Circulation. 2018 Sep 21. doi: 10.1161/CIRCULATIONAHA.118.036701.
    PubMed     Text format     Abstract available


  21. DAWSON J
    Pioglitazone Use After Stroke.
    Circulation. 2018;138:1221-1223.
    PubMed     Text format    


  22. KOH KK
    Letter by Koh Regarding Article, "PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)".
    Circulation. 2018;138:1283-1284.
    PubMed     Text format    


  23. DE VEER AJWM, Bennaghmouch N, Mahmoodi BK, Ten Berg JM, et al
    Response by de Veer et al to Letter Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Tria
    Circulation. 2018;138:1279.
    PubMed     Text format    


  24. TONG S, Zhang L, Joseph J
    Letter by Tong et al Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials".
    Circulation. 2018;138:1277-1278.
    PubMed     Text format    


  25. COLOMBO PC, Mehra MR, Goldstein DJ, Estep JD, et al
    Comprehensive Analysis of Stroke in the LongTerm Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump.
    Circulation. 2018 Sep 17. doi: 10.1161/CIRCULATIONAHA.118.037231.
    PubMed     Text format     Abstract available


    July 2018
  26. OVERVAD TF, Larsen TB, Nielsen PB
    Response by Overvad et al to Letter Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?"
    Circulation. 2018;138:443-444.
    PubMed     Text format    


  27. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VASc-VA Score Rather Than CHA2DS2-VASc?"
    Circulation. 2018;138:441-442.
    PubMed     Text format    


  28. AL SULTAN AS, Hill MD
    Acute Ischemic Stroke Biology Demands Fast Treatment.
    Circulation. 2018;138:241-243.
    PubMed     Text format    


  29. SHEN YM, Nagalla S
    Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.
    Circulation. 2018;138:229-231.
    PubMed     Text format    


  30. GOLD MR
    Response by Gold to Letter Regarding Article, "Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?"
    Circulation. 2018;138:124.
    PubMed     Text format    


  31. REIFFEL JA
    Letter by Reiffel Regarding Article, "Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?"
    Circulation. 2018;138:122-123.
    PubMed     Text format    


    June 2018
  32. YOUNG LH, Viscoli CM, Schwartz GG, Inzucchi SE, et al
    Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone.
    Circulation. 2018 Jun 22. pii: CIRCULATIONAHA.118.034763.
    PubMed     Text format     Abstract available


  33. BOHULA EA, Wiviott SD, Giugliano RP, Park JG, et al
    Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Circulation. 2018;137:2662-2663.
    PubMed     Text format    


  34. KOH KK
    Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2660-2661.
    PubMed     Text format    


  35. CORDERO A, Bertomeu-Gonzalez V, Rodriguez-Manero M
    Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2658-2659.
    PubMed     Text format    


  36. THOMOPOULOS C, Michalopoulou H
    Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Tr
    Circulation. 2018;137:2656-2657.
    PubMed     Text format    


  37. DEL PINTO R, Ferri C, Borghi C
    Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2654-2655.
    PubMed     Text format    


  38. SHARMA A, Hijazi Z, Andersson U, Al-Khatib SM, et al
    The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Circulation. 2018 Jun 5. pii: CIRCULATIONAHA.118.034125.
    PubMed     Text format     Abstract available


    May 2018
  39. MEHRA MR, Salerno C, Cleveland JC, Pinney S, et al
    Health Care Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: A Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure.
    Circulation. 2018 May 27. pii: CIRCULATIONAHA.118.035722.
    PubMed     Text format     Abstract available


  40. NAZHA B, Pandya B, Cohen J, Zhang M, et al
    Periprocedural Outcomes of Direct Oral Anticoagulants vs. Warfarin in Non-Valvular Atrial Fibrillation: A Meta-analysis of Phase III Trials.
    Circulation. 2018 May 24. pii: CIRCULATIONAHA.117.031457.
    PubMed     Text format     Abstract available


  41. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    PubMed     Text format    


    April 2018
  42. O'BRIEN EC, Holmes DN, Thomas LE, Fonarow GC, et al
    Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation.
    Circulation. 2018 Apr 20. pii: CIRCULATIONAHA.117.031354.
    PubMed     Text format     Abstract available


  43. CHEN LY, Chung MK, Allen LA, Ezekowitz M, et al
    Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 16. pii: CIR.0000000000000568.
    PubMed     Text format     Abstract available


  44. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Response by Lau et al to Letters Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1534-1535.
    PubMed     Text format    


  45. SPARTALIS M, Tzatzaki E, Spartalis E
    Letter by Spartalis et al Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1528-1529.
    PubMed     Text format    


    March 2018
  46. BEHESHTI S, Madsen CM, Varbo A, Benn M, et al
    Relationship of Familial Hypercholesterolemia and High LDL Cholesterol to Ischemic Stroke: The Copenhagen General Population Study.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.118.033470.
    PubMed     Text format     Abstract available


  47. MULDER MJHL, Jansen IGH, Goldhoorn RB, Venema E, et al
    Time to Endovascular Treatment and Outcome in Acute Ischemic Stroke: MR CLEAN Registry Results.
    Circulation. 2018 Mar 26. pii: CIRCULATIONAHA.117.032600.
    PubMed     Text format     Abstract available


    February 2018
  48. CHAO TF, Liu CJ, Lin YJ, Chang SL, et al
    Oral Anticoagulation in Very Elderly Patients with Atrial Fibrillation - A Nationwide Cohort Study.
    Circulation. 2018 Feb 28. pii: CIRCULATIONAHA.117.031658.
    PubMed     Text format     Abstract available


  49. HICKS KA, Mahaffey KW, Mehran R, Nissen SE, et al
    2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
    Circulation. 2018;137:961-972.
    PubMed     Text format     Abstract available


  50. NIELSEN PB, Skjoth F, Overvad TF, Larsen TB, et al
    Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
    Circulation. 2018;137:832-840.
    PubMed     Text format     Abstract available



  51. Correction to: Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Pr
    Circulation. 2018;137:e29.
    PubMed     Text format    


    January 2018
  52. BENJAMIN EJ, Virani SS, Callaway CW, Chang AR, et al
    Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.
    Circulation. 2018 Jan 31. pii: CIR.0000000000000558.
    PubMed     Text format    


  53. ALBERTS MJ, Ollenschleger MD, Nouh A
    DAWN of a New Era for Stroke Treatment: Implications of the DAWN Study for Acute Stroke Care and Stroke Systems of Care.
    Circulation. 2018 Jan 18. pii: CIRCULATIONAHA.118.033579.
    PubMed     Text format     Abstract available


  54. GOLD MR
    Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?
    Circulation. 2018;137:217-218.
    PubMed     Text format    


  55. EMDIN CA, Khera AV, Klarin D, Natarajan P, et al
    Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling.
    Circulation. 2018;137:222-232.
    PubMed     Text format     Abstract available


  56. VEDEL AG, Holmgaard F, Rasmussen LS, Langkilde A, et al
    High-Target vs Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients - A Randomized Controlled Trial.
    Circulation. 2018 Jan 16. pii: CIRCULATIONAHA.117.030308.
    PubMed     Text format     Abstract available


  57. JOLLY SS, Gao P, Cairns JA, Yusuf S, et al
    Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI).
    Circulation. 2018;137:206-209.
    PubMed     Text format    


  58. BARANCHUK A, Torner P, de Luna AB
    Bayes Syndrome: What Is It?
    Circulation. 2018;137:200-202.
    PubMed     Text format    


  59. FISHER M, Hill JA
    Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Circulation. 2018;137:103-105.
    PubMed     Text format    


  60. LEE JZ, Ling J, Diehl NN, Hodge DO, et al
    Mortality and Cerebrovascular Events After Heart Rhythm Disorder Management Procedures.
    Circulation. 2018;137:24-33.
    PubMed     Text format     Abstract available


    December 2017
  61. NTAIOS G, Hart RG
    Embolic Stroke.
    Circulation. 2017;136:2403-2405.
    PubMed     Text format    


  62. GOLDSTONE AB, Chiu P, Baiocchi M, Wang H, et al
    Second Arterial versus Venous Conduits for Multi-Vessel Coronary Artery Bypass Surgery in California.
    Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.030959.
    PubMed     Text format     Abstract available


  63. CAMPBELL BCV, Donnan GA, Davis SM
    Optimizing Systems of Care for Endovascular Thrombectomy in Ischemic Stroke: Drip and Ship Versus Mothership.
    Circulation. 2017;136:2322-2324.
    PubMed     Text format    


    November 2017
  64. MEFFORD MT, Rosenson RS, Cushman M, Farkouh ME, et al
    PCSK9 Variants, LDL-Cholesterol, and Neurocognitive Impairment: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Circulation. 2017 Nov 16. pii: CIRCULATIONAHA.117.029785.
    PubMed     Text format     Abstract available


  65. KHERA R, Hong JC, Saxena A, Arrieta A, et al
    Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.030128.
    PubMed     Text format     Abstract available


  66. BENNAGHMOUCH N, de Veer AJWM, Bode K, Mahmoodi BK, et al
    The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028513.
    PubMed     Text format     Abstract available


    October 2017
  67. YAGHI S, Furie KL, Viscoli CM, Kamel H, et al
    Pioglitazone Prevents Stroke in Patients with a Recent TIA or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial.
    Circulation. 2017 Oct 30. pii: CIRCULATIONAHA.117.030458.
    PubMed     Text format     Abstract available


  68. YOUNG LH, Viscoli CM, Inzucchi SE, Kernan WN, et al
    Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1567-1568.
    PubMed     Text format    


  69. JIN-SHAN H, Xue-Bin L
    Letter by Jin-Shan and Xue-Bin Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1565-1566.
    PubMed     Text format    


  70. MUSSO G, Cassader M, Gambino R
    Letter by Musso et al Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1563-1564.
    PubMed     Text format    


  71. SUNDBOLL J, Hovath-Puho E, Adelborg K, Schmidt M, et al
    Higher Risk of Vascular Dementia in Myocardial Infarction Survivors.
    Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.029127.
    PubMed     Text format     Abstract available


  72. SMITH EE, Saver JL, Cox M, Liang L, et al
    Increase in Endovascular Therapy in Get With The Guidelines-Stroke After The Publication of Pivotal Trials.
    Circulation. 2017 Oct 5. pii: CIRCULATIONAHA.117.031097.
    PubMed     Text format     Abstract available


    September 2017
  73. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    PubMed     Text format     Abstract available


  74. FROEHLER MT, Saver JL, Zaidat OO, Jahan R, et al
    Interhospital Transfer Prior to Thrombectomy is Associated with Delayed Treatment and Worse Outcome in the STRATIS Registry.
    Circulation. 2017 Sep 24. pii: CIRCULATIONAHA.117.028920.
    PubMed     Text format     Abstract available


    August 2017
  75. ARMSTRONG PW, Welsh RC
    Recalibrating Reperfusion Waypoints.
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030869.
    PubMed     Text format     Abstract available


  76. PU J, Ding S, Ge H, Han Y, et al
    Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Ac
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030582.
    PubMed     Text format     Abstract available


  77. HOPKINS LN, Holmes DR Jr
    Response by Hopkins and Holmes to Letter Regarding Article, "Public Health Urgency Created by the Success of Mechanical Thrombectomy Studies in Stroke".
    Circulation. 2017;136:781-782.
    PubMed     Text format    



  78. Letter by the Society of NeuroInterventional Surgery, the Cerebrovascular Section of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons, and the Society of Vascular and Interventional Neurology Regarding Articl
    Circulation. 2017;136:779-780.
    PubMed     Text format    


  79. KALMAN JM, Sanders P, Rosso R, Calkins H, et al
    Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
    Circulation. 2017;136:490-499.
    PubMed     Text format     Abstract available


    July 2017
  80. HELLER DJ, Coxson PG, Penko J, Pletcher MJ, et al
    Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027067.
    PubMed     Text format     Abstract available


  81. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    PubMed     Text format     Abstract available


    June 2017
  82. EASTON JD, Aunes M, Albers GW, Amarenco P, et al
    Risk for Major Bleeding in Patients Receiving Ticagrelor Compared with Aspirin After TIA or Acute Ischemic Stroke in the SOCRATES Study.
    Circulation. 2017 Jun 27. pii: CIRCULATIONAHA.117.028566.
    PubMed     Text format     Abstract available


  83. BIVARD A, Muir K, Parsons M
    Response by Bivard et al to Letter Regarding Article, "Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials".
    Circulation. 2017;135:e1141-e1142.
    PubMed     Text format    


  84. ROOZENBEEK B, Dippel DWJ, Lingsma HF
    Letter by Roozenbeek et al Regarding Article, "Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials".
    Circulation. 2017;135:e1139-e1140.
    PubMed     Text format    


  85. FLEVARIS P, Khan SS, Eren M, Schuldt AJ, et al
    PAI-1 Controls Cardiomyocyte TGF-beta and Cardiac Fibrosis.
    Circulation. 2017 Jun 6. pii: CIRCULATIONAHA.117.028145.
    PubMed     Text format     Abstract available


    May 2017
  86. JOLLY SS, James S, Dzavik V, Cairns JA, et al
    Response by Jolly et al to Letters Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1103-e1104.
    PubMed     Text format    


  87. SHAH R
    Letter by Shah Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1101-e1102.
    PubMed     Text format    


  88. JURADO-ROMAN A, Sanchez-Perez I, Lozano-Ruiz-Poveda F
    Letter by Jurado-Roman et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1099-e1100.
    PubMed     Text format    


  89. KARAMASIS GV, Davies JR, Clesham GJ
    Letter by Karamasis et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1097-e1098.
    PubMed     Text format    


  90. DALE C, Fatemifar G, Palmer T, White J, et al
    Causal Associations of Adiposity and Body Fat Distribution with Coronary Heart Disease, Stroke Subtypes and Type 2 Diabetes: A Mendelian Randomization Analysis.
    Circulation. 2017 May 12. pii: CIRCULATIONAHA.116.026560.
    PubMed     Text format     Abstract available


  91. MARTINEZ DE LIZARRONDO S, Gakuba C, Herbig BA, Repesse Y, et al
    Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.
    Circulation. 2017 May 9. pii: CIRCULATIONAHA.117.027290.
    PubMed     Text format     Abstract available


  92. FREEDMAN B, Camm J, Calkins H, Healey JS, et al
    Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.
    Circulation. 2017;135:1851-1867.
    PubMed     Text format     Abstract available


    April 2017
  93. URIEL N, Colombo PC, Cleveland JC, Long JW, et al
    Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Circulation. 2017 Apr 6. pii: CIRCULATIONAHA.117.028303.
    PubMed     Text format     Abstract available


  94. HUNTER AL, Shah AS, Langrish JP, Raftis JB, et al
    Fire Simulation and Cardiovascular Health in Firefighters.
    Circulation. 2017;135:1284-1295.
    PubMed     Text format     Abstract available


    March 2017
  95. HOPKINS LN, Holmes DR Jr
    Public Health Urgency Created by the Success of Mechanical Thrombectomy Studies in Stroke.
    Circulation. 2017;135:1188-1190.
    PubMed     Text format    


  96. BRIGHT CJ, Hawkins MM, Guha J, Henson KE, et al
    Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).
    Circulation. 2017;135:1194-1210.
    PubMed     Text format     Abstract available


  97. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.
    Circulation. 2017;135:1123-1132.
    PubMed     Text format     Abstract available


  98. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Text format     Abstract available


    February 2017
  99. CAVENDER MA, White WB, Jarolim P, Bakris GL, et al
    Serial Measurement of High Sensitivity Troponin I and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus in the EXAMINE Trial.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024632.
    PubMed     Text format     Abstract available


  100. YOUNG LH, Viscoli CM, Curtis JP, Inzucchi SE, et al
    Cardiac Outcomes After Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance Without Diabetes.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024863.
    PubMed     Text format     Abstract available


  101. CARNICELLI AP, De Caterina R, Halperin JL, Renda G, et al
    Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.026714.
    PubMed     Text format     Abstract available


  102. DUFOUIL C, Beiser AS, McClure LA, Wolf PA, et al
    A Revised Framingham Stroke Risk Profile to Reflect Temporal Trends.
    Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.115.021275.
    PubMed     Text format     Abstract available


    January 2017
  103. XIAN Y, Federspiel JJ, Hernandez AF, Laskowitz D, et al
    Use of Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Before Stroke.
    Circulation. 2017 Jan 24. pii: CIRCULATIONAHA.116.023940.
    PubMed     Text format     Abstract available


  104. OVBIAGELE B, Wang J, Johnston SC, Wang A, et al
    Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention.
    Circulation. 2017;135:315-316.
    PubMed     Text format    


  105. ALBERTS MJ
    Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator: More Proof That Time Is Brain.
    Circulation. 2017;135:140-142.
    PubMed     Text format    


  106. WANG W, Jiang B, Sun H, Ru X, et al
    Prevalence, Incidence and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480,687 Adults.
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.025250.
    PubMed     Text format     Abstract available


    December 2016
  107. SINGH S, Houng AK, Reed GL
    Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and alpha2-Antiplasmin Inactivation.
    Circulation. 2016 Dec 27. pii: CIRCULATIONAHA.116.024421.
    PubMed     Text format     Abstract available


  108. SCHWAMM LH, Chumbler N, Brown E, Fonarow GC, et al
    Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
    Circulation. 2016 Dec 20. pii: CIR.0000000000000475.
    PubMed     Text format     Abstract available


  109. BIVARD A, Huang X, McElduff P, Levi CR, et al
    The Impact of CT Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke. Analysis of Two Randomized Controlled Trials.
    Circulation. 2016 Dec 13. pii: CIRCULATIONAHA.116.022582.
    PubMed     Text format     Abstract available


  110. JOLLY SS, James SK, Dzavik V, Cairns JA, et al
    Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.
    Circulation. 2016 Dec 9. pii: CIRCULATIONAHA.116.025371.
    PubMed     Text format     Abstract available


    November 2016
  111. MELDUNI RM, Schaff HV, Lee HC, Gersh BJ, et al
    Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score Matched Analysis of 10,633 Patients.
    Circulation. 2016 Nov 30. pii: CIRCULATIONAHA.116.021952.
    PubMed     Text format     Abstract available


  112. GIBSON CM, Chi G, Halaby R, Korjian S, et al
    Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025427.
    PubMed     Text format     Abstract available


  113. MENON BK, Hill MD, Goyal M
    Response by Menon et al to Letter Regarding Article, "Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial".
    Circulation. 2016;134:e406-e407.
    PubMed     Text format    


  114. VENEMA E, Lingsma HF, Dippel DW
    Letter by Venema et al Regarding Article, "Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial".
    Circulation. 2016;134:e404-e405.
    PubMed     Text format    


  115. ZUHLKE L, Karthikeyan G, Engel ME, Rangarajan S, et al
    Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
    Circulation. 2016;134:1456-1466.
    PubMed     Text format     Abstract available


  116. KIM JT, Fonarow GC, Smith EE, Reeves MJ, et al
    Treatment with TPA in the "Golden Hour" and the Shape of the 4.5 Hour Time-Benefit Curve in the National US Get With The Guidelines-Stroke Population.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023336.
    PubMed     Text format     Abstract available


  117. PAN Y, Chen W, Xu Y, Yi X, et al
    Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-analysis.
    Circulation. 2016 Nov 2. pii: CIRCULATIONAHA.116.024913.
    PubMed     Text format     Abstract available


  118. HALPERIN JL, Savino JA 3rd
    Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End
    Circulation. 2016;134:e391-e392.
    PubMed     Text format    


  119. NIELSEN PB, Lip GY
    Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke".
    Circulation. 2016;134:e389-e390.
    PubMed     Text format    


  120. ASINGER RW, Shroff GR, Herzog CA
    Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patie
    Circulation. 2016;134:e387-e388.
    PubMed     Text format    


    October 2016
  121. QUINN GR, Severdija ON, Chang Y, Singer DE, et al
    Wide Variation in Reported Rates of Stroke Across Cohorts of Patients with Atrial Fibrillation.
    Circulation. 2016 Oct 31. pii: CIRCULATIONAHA.116.024057.
    PubMed     Text format     Abstract available


  122. YANAGAWA B, Pettersson GB, Habib G, Ruel M, et al
    Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Practical Recommendations for Clinicians.
    Circulation. 2016;134:1280-1292.
    PubMed     Text format     Abstract available


    September 2016
  123. KAASENBROOD L, Boekholdt SM, van der Graaf Y, Ray KK, et al
    Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.021314.
    PubMed     Text format     Abstract available


  124. SEIDELMANN SB, Claggett B, Bravo PE, Gupta A, et al
    Retinal Vessel Calibers in Predicting Long-term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.023425.
    PubMed     Text format     Abstract available


  125. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e230-1.
    PubMed     Text format    


  126. YANG X, An R, Xu Y
    Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e228-9.
    PubMed     Text format    


  127. CHAN PH, Siu CW
    Letter by Chan and Siu Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e226-7.
    PubMed     Text format    


  128. LONN EM, Yusuf S
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mmHg Target?: An Antagonist View from HOPE-3.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023264.
    PubMed     Text format     Abstract available


    August 2016
  129. BONACA MP, Goto S, Bhatt DL, Steg PG, et al
    Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-T
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024637.
    PubMed     Text format     Abstract available


  130. OLDGREN J, Hijazi Z, Lindback J, Alexander JH, et al
    Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Circulation. 2016 Aug 28. pii: CIRCULATIONAHA.116.022802.
    PubMed     Text format     Abstract available


  131. BRAUN LT, Grady KL, Kutner JS, Adler E, et al
    Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association.
    Circulation. 2016 Aug 8. pii: CIR.0000000000000438.
    PubMed     Text format     Abstract available


  132. LIP GY
    Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring".
    Circulation. 2016;134:e30-1.
    PubMed     Text format    


    July 2016
  133. PERALTA CA, McClure LA, Scherzer R, Odden MC, et al
    Response by Peralta et al to Letter Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Stroke
    Circulation. 2016;134:e26-7.
    PubMed     Text format    


  134. MEZUE K, Puri R, Rangaswami J
    Letter by Mezue et al Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Rando
    Circulation. 2016;134:e24-5.
    PubMed     Text format    


  135. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    PubMed     Text format     Abstract available


  136. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e7-8.
    PubMed     Text format    


  137. IMPRIALOS K, Boutari C, Stavropoulos K
    Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e5-6.
    PubMed     Text format    


  138. BOUATOU Y, El Biali M, Samer CF
    Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e3-4.
    PubMed     Text format    


  139. HERRMANN HC, Thourani VH, Kodali SK, Makkar RR, et al
    One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Circulation. 2016;134:130-40.
    PubMed     Text format     Abstract available


  140. HIJAZI Z, Wallentin L
    Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.
    Circulation. 2016;134:48-51.
    PubMed     Text format    


  141. FORDYCE CB, Hellkamp AS, Lokhnygina Y, Lindner SM, et al
    On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
    Circulation. 2016;134:37-47.
    PubMed     Text format     Abstract available


    June 2016
  142. MENON BK, Sajobi TT, Zhang Y, Rempel JL, et al
    Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial.
    Circulation. 2016;133:2279-86.
    PubMed     Text format     Abstract available


    May 2016
  143. SACCO RL, Roth GA, Reddy KS, Arnett DK, et al
    The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
    Circulation. 2016 May 9. pii: CIR.0000000000000395.
    PubMed     Text format     Abstract available


  144. KEHREL BE, Fender AC
    Resolving Thromboinflammation in the Brain After Ischemic Stroke?
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.116.022858.
    PubMed     Text format     Abstract available


  145. VITAL SA, Becker F, Holloway PM, Russell J, et al
    Fpr2/ALX Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.115.020633.
    PubMed     Text format     Abstract available


  146. NAYOR M, Vasan RS
    Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.
    Circulation. 2016;133:1795-806.
    PubMed     Text format     Abstract available


    March 2016
  147. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    The Use of Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with History of Intra-Cranial Hemorrhage.
    Circulation. 2016 Mar 11. pii: CIRCULATIONAHA.115.019794.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: